These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 11116209
1. Effects of a thyromimetic on apolipoprotein B-100 in rats. Wada Y, Matsubara S, Dufresne J, Hargrove GM, Stephan ZF, Steele RE, Wong NC. J Mol Endocrinol; 2000 Dec; 25(3):299-308. PubMed ID: 11116209 [Abstract] [Full Text] [Related]
2. Distinct promoters induce APOBEC-1 expression in rat liver and intestine. Greeve J, Axelos D, Welker S, Schipper M, Greten H. Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068 [Abstract] [Full Text] [Related]
3. Apolipoprotein B mRNA editing is preserved in the intestine and liver of zinc-deficient rats. Nassir F, Blanchard RK, Mazur A, Cousins RJ, Davidson NO. J Nutr; 1996 Apr; 126(4):860-4. PubMed ID: 8613888 [Abstract] [Full Text] [Related]
4. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Taylor AH, Stephan ZF, Steele RE, Wong NC. Mol Pharmacol; 1997 Sep; 52(3):542-7. PubMed ID: 9281617 [Abstract] [Full Text] [Related]
10. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing. Mehta A, Driscoll DM. RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661 [Abstract] [Full Text] [Related]
11. Apobec-1 and apolipoprotein B mRNA editing. Chan L, Chang BH, Nakamuta M, Li WH, Smith LC. Biochim Biophys Acta; 1997 Mar 10; 1345(1):11-26. PubMed ID: 9084497 [Abstract] [Full Text] [Related]
12. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition. Elam MB, von Wronski MA, Cagen L, Thorngate F, Kumar P, Heimberg M, Wilcox HG. Lipids; 1999 Aug 10; 34(8):809-16. PubMed ID: 10529091 [Abstract] [Full Text] [Related]
13. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Lehmann DM, Galloway CA, Sowden MP, Smith HC. Nucleic Acids Res; 2006 Aug 10; 34(11):3299-308. PubMed ID: 16820530 [Abstract] [Full Text] [Related]
14. Apolipoprotein B messenger RNA editing: an update. Chan L. Biochimie; 1995 Aug 10; 77(1-2):75-8. PubMed ID: 7599279 [Abstract] [Full Text] [Related]
15. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Qian X, Balestra ME, Yamanaka S, Borén J, Lee I, Innerarity TL. Arterioscler Thromb Vasc Biol; 1998 Jun 10; 18(6):1013-20. PubMed ID: 9633945 [Abstract] [Full Text] [Related]
16. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Morrison JR, Pászty C, Stevens ME, Hughes SD, Forte T, Scott J, Rubin EM. Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):7154-9. PubMed ID: 8692961 [Abstract] [Full Text] [Related]
17. Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue. Davidson NO. Ann Med; 1993 Dec 09; 25(6):539-43. PubMed ID: 8292303 [Abstract] [Full Text] [Related]
18. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Siddiqui JF, Van Mater D, Sowden MP, Smith HC. Exp Cell Res; 1999 Oct 10; 252(1):154-64. PubMed ID: 10502408 [Abstract] [Full Text] [Related]
19. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing. Sowden MP, Eagleton MJ, Smith HC. Nucleic Acids Res; 1998 Apr 01; 26(7):1644-52. PubMed ID: 9512534 [Abstract] [Full Text] [Related]
20. Apolipoprotein B mRNA editing protein: a tool for dissecting lipoprotein metabolism and a potential therapeutic gene for hypercholesterolemia. Chan L, Teng BB, Lau P. Z Gastroenterol; 1996 Jun 01; 34 Suppl 3():31-2. PubMed ID: 8767453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]